Statins in COPD: Selection Modalities and Mortalities

[摘要] Cardiovascular disease contributes a significant share to the all-cause mortality of COPD¹; therefore it is sensible to assume similar positive outcomes with its mortality benefiting measures in the COPD group as well. The study by Raymakers et al² published in CHEST (September 2017) found a significant all-cause and COPD-related mortality benefit with the use of statin drugs. The inclusion of a vast number of participants from databases, with a follow-up of a reasonable duration and a focus on adherence to statin drug use are the strengths of this retrospective study.

[学科分类] 呼吸医学